These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20700647)

  • 21. Circulating tumor cells in breast cancer.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
    Bregni M; Fleischhauer K; Bernardi M; Pescarollo A; Guggiari E; Lunghi F; Deola S; Scaramuzza S; Re F; Setola E; Monari M; Mazzi B; Servida P; Corradini P; Peccatori J
    Bone Marrow Transplant; 2006 Feb; 37(3):311-5. PubMed ID: 16400340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical significance of circulating tumor cells.
    Pantel K; Alix-Panabières C
    Nat Clin Pract Oncol; 2007 Feb; 4(2):62-3. PubMed ID: 17259923
    [No Abstract]   [Full Text] [Related]  

  • 24. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
    Yoneda T; Hiraga T
    Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HER2 as marker for the detection of circulating tumor cells.
    Müller V; Pantel K
    Breast Cancer Res Treat; 2009 Oct; 117(3):535-7. PubMed ID: 19115105
    [No Abstract]   [Full Text] [Related]  

  • 27. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
    Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
    Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis].
    Ke F; Wu JM; Yao JE; Bai YJ; Guo AL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2257-61. PubMed ID: 18001545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand binding prediction for BRCA1, a key molecule in the pathogenesis of breast cancer.
    Wiwanitkit V
    Indian J Cancer; 2010; 47(2):139-41. PubMed ID: 20448375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An ideal prognostic test for estrogen receptor-positive breast cancer?
    Paik S; Tang G; Fumagalli D
    J Clin Oncol; 2008 Sep; 26(25):4058-9. PubMed ID: 18678837
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitative biology: a new paradigm for tumor profiling, prognosis, and treatment.
    Heaton AH
    Manag Care; 2008 Jul; 17(7 Suppl 7):3; discussion 17-8. PubMed ID: 19097281
    [No Abstract]   [Full Text] [Related]  

  • 33. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
    Parr C; Jiang WG
    Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ["Prognostic factors" in breast cancer--1].
    Brockmann B; Reitzig P
    Z Arztl Fortbild (Jena); 1994 Feb; 88(2):111-4. PubMed ID: 8147017
    [No Abstract]   [Full Text] [Related]  

  • 35. Gene expression profiling in breast cancer.
    Morris SR; Carey LA
    Curr Opin Oncol; 2007 Nov; 19(6):547-51. PubMed ID: 17906450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vascular endothelial growth factor and two types of its receptors in breast cancer].
    Shcherbakov AM; Gershteĭn ES; Anurova OA; Kushlinskiĭ NE
    Vopr Onkol; 2005; 51(3):317-21. PubMed ID: 16279095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
    Pantel K; Müller V; Auer M; Nusser N; Harbeck N; Braun S
    Clin Cancer Res; 2003 Dec; 9(17):6326-34. PubMed ID: 14695131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC; Garcao F; Coutinho EC; De Oliveira CF; Regateiro FJ
    Neoplasma; 2006; 53(6):538-43. PubMed ID: 17167725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial to mesenchymal transition: the doorway to metastasis in human lung cancers.
    Denlinger CE; Ikonomidis JS; Reed CE; Spinale FG
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):505-13. PubMed ID: 20723721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.